sorbitan monostearate has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdellatif, KRA; Abo El-Ela, FI; F, AG; Kharshoum, RM; Salem, HF | 1 |
| Double, JA; Florence, AT; Kelland, LR; Turton, JA; Uchegbu, IF | 1 |
2 other study(ies) available for sorbitan monostearate and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Cholesterol; Delayed-Action Preparations; Drug Liberation; Female; Gold; Hexoses; Hydrogen-Ion Concentration; Liposomes; Metal Nanoparticles; Mice; Tamoxifen; Tissue Distribution | 2018 |
The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Antibiotics, Antineoplastic; Binding Sites; Carcinoma, Ehrlich Tumor; Coated Vesicles; Doxorubicin; Drug Compounding; Drug Delivery Systems; Drug Resistance, Multiple; Female; Glyceryl Ethers; Hexoses; Injections, Intravenous; Lethal Dose 50; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Surface-Active Agents; Tumor Cells, Cultured | 1996 |